✦ LIBER ✦

Expression of the Uptake Drug Transporter hOCT1 is an Important Clinical Determinant of the Response to Imatinib in Chronic Myeloid Leukemia

✍ Scribed by Wang, L; Giannoudis, A; Lane, S; Williamson, P; Pirmohamed, M; Clark, RE

Book ID: 110020125
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 230 KB
Volume: 83
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.6100268

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical significance of CD34 expres

The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia : An overview of 2483 patients from 22 studies

✍ Yoshinobu Kanda; Tamae Hamaki; Rie Yamamoto; Aki Chizuka; Miyuki Suguro; Tomohir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

## BACKGROUND. Although many studies have been performed to evaluate the prognostic significance of CD34 expression in acute myeloid leukemia (AML), the findings have been inconsistent. In this study, the authors reviewed such previous studies to establish a definite conclusion. ## METHODS. Usi

Adherence to the standard dose of imatin

Adherence to the standard dose of imatinib, rather than dose adjustment based on its plasma concentration, is critical to achieve a deep molecular response in patients with chronic myeloid leukemia

✍ Chikashi Yoshida; Takuya Komeno; Mitsuo Hori; Tomofumi Kimura; Masami Fujii; Yas 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 162 KB